Skip to main content

Table 1 Comparison between the studied groups regarding serum levels of LH & TGF-B

From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

Parameters

Group

F (P)

Control

Benign

Borderline

Malignant

 

LH (Mean ± SD)

8.7 ± 1.6

18.8 d ± 4.4

4.5 ± 0.9

3.7 ± 1.4

0.001*

TGF-B (Mean ± SD)

1347.4 ± 594.2

1039.0 ± 686.4

994 ± 547.6

894.0 ± 547.6

0.065

  1. F One Way ANOVA, d significantly different group (s), *P < 0.05 (significant)